home / stock / sana / sana news


SANA News and Press, Sana Biotechnology Inc.

Stock Information

Company Name: Sana Biotechnology Inc.
Stock Symbol: SANA
Market: NASDAQ
Website: sana.com

Menu

SANA SANA Quote SANA Short SANA News SANA Articles SANA Message Board
Get SANA Alerts

News, Short Squeeze, Breakout and More Instantly...

SANA - Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

2026-03-06 13:46:04 ET Sana Biotechnology, Inc. (SANA) TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM EST... Read the full article on Seeking Alpha For further details see: Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Confer...

SANA - Buy Recommendation Issued On SANA By H.C. Wainwright

2026-03-04 08:15:09 ET H.C. Wainwright analyst issues BUY recommendation for SANA on March 4, 2026 11:41AM ET. The previous analyst recommendation was Buy. SANA was trading at $3.93 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...

SANA - Sana Biotechnology GAAP EPS of -$0.21 misses by $0.07

2026-03-03 16:25:30 ET More on Sana Biotechnology Sana Biotechnology: A Small, Speculative Play Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

SANA - Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression are safe and well-tolerated, evade detection by the immune system, and continue to function one year post-transplant New Engla...

SANA - Sana Biotechnology to Present at March 2026 Investor Conferences

SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in March. The presentations will feature a busin...

SANA - Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of Brian Piper as Executive Vice President, Chief Financial Officer. Mr. Piper brings to Sana a bre...

SANA - Sana Biotechnology: A Small, Speculative Play

2026-02-13 03:24:54 ET Shares of engineered cell concern Sana Biotechnology, Inc. ( SANA ) have nearly tripled off their recent lows in early April, mostly on the strength of data from one type 1 diabetes patient who received a precursor to its SC451. The clinical data not only ...

SANA - Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

2026-01-19 07:40:15 ET ... Read the full article on Seeking Alpha For further details see: Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

SANA - Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 15:26:02 ET Sana Biotechnology, Inc. (SANA) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 12:45 PM EST... Read the full article on Seeking Alpha For further details see: Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcar...

SANA - Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44 th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT o...

Next 10